Switching from intravenous to oral antibiotics in hospitalized patients with community-acquired pneumonia: A real-world analysis 2010–2018

Kimura, Tomomi; Ito, Masanori; Onozawa, Satoshi

doi:10.1016/j.jiac.2020.03.010

Cited by 6 publications

(2 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In a study conducted in Japan, sequential therapy was performed in 30.1% of patients, and was more frequent among mild patients and in people treated by pulmonologists [ 111 ]. Early intravenous-to-oral conversion of antibiotic therapy is safe, with the same rate of mortality, recurrent infections, and treatment success than exclusive intravenous therapy; and it is associated with a shorter length of hospital stay and lower costs [ 112 , 113 ].…”

Section: Resultsmentioning

confidence: 99%

Candent issues in pneumonia. Reflections from the Fifth Annual Meeting of Spanish Experts 2023

Rodríguez-Leal,

González-Corralejo,

Candel

et al. 2024

Rev Esp Quimioter

View full text Add to dashboard Cite

Pneumonia is a multifaceted illness with a wide range of clinical manifestations, degree of severity and multiple potential causing microorganisms. Despite the intensive research of recent decades, community-acquired pneumonia remains the third-highest cause of mortality in developed countries and the first due to infections; and hospital-acquired pneumonia is the main cause of death from nosocomial infection in critically ill patients. Guidelines for management of this disease are available world wide, but there are questions which generate controversy, and the latest advances make it difficult to stay them up to date. A multidisciplinary approach can overcome these limitations and can also aid to improve clinical results. Spanish medical societies involved in diagnosis and treatment of pneumonia have made a collaborative effort to actualize and integrate last expertise about this infection. The aim of this paper is to reflect this knowledge, communicated in Fifth Pneumonia Day in Spain. It reviews the most important questions about this disorder, such as microbiological diagnosis, advances in antibiotic and sequential therapy, management of beta-lactam allergic patient, preventive measures, management of unusual or multi-resistant microorganisms and adjuvant or advanced therapies in Intensive Care Unit.

show abstract

Section: Resultsmentioning

confidence: 99%

Candent issues in pneumonia. Reflections from the Fifth Annual Meeting of Spanish Experts 2023

Rodríguez-Leal,

González-Corralejo,

Candel

et al. 2024

Rev Esp Quimioter

View full text Add to dashboard Cite

show abstract

“…In a study conducted in Japan, sequential therapy was performed in 30.1% of patients, and was more frequent among mild patients and in people treated by pulmonologists [111]. Early intravenous-to-oral conversion of antibiotic therapy is safe, with the same rate of mortality, recurrent infections, and treatment success than exclusive intravenous therapy; and it is associated with a shorter length of hospital stay and lower costs [112,113].…”

Section: Therapeutic Optimisation In Community-acquired Pneumoniamentioning

confidence: 99%

Untitled

2024

Rev Esp Quimioter

View full text Add to dashboard Cite

show abstract

Promotion of antimicrobial stewardship following issuance of the antimicrobial resistance national action plan in Japan: A systematic review of 2016–2020

Honda

Goto

Uehara

et al. 2023

International Journal of Antimicrobial Agents

View full text Add to dashboard Cite

Switching from intravenous to oral antibiotics in hospitalized patients with community-acquired pneumonia: A real-world analysis 2010–2018

Cited by 6 publications

References 19 publications

Candent issues in pneumonia. Reflections from the Fifth Annual Meeting of Spanish Experts 2023

Candent issues in pneumonia. Reflections from the Fifth Annual Meeting of Spanish Experts 2023

Untitled

Promotion of antimicrobial stewardship following issuance of the antimicrobial resistance national action plan in Japan: A systematic review of 2016–2020

Contact Info

Product

Resources

About